semaglutide & tirzepatide weight loss versus Once Weekly in Patients with Type 2 Diabetes Semaglutide and tirzepatide treatment leads

FEBS letters

S.BaumbachA.BhmM.et al (2023)

The conventional statistical significance threshold of 0.05 was used, without a hierarchical testing, except that secondary endpoints were analysed only when significance on the primary endpoint was met

This finding expands the potential benefits of the drug beyond just the number on the scale

GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) are increasingly being considered as adjunctive therapy in post-bariatric patients

Another experimental study found that the combination of statins with PCSK9 inhibitors was more effective than statins alone (239)